Radiotherapy with concomitant temozolomide in WHO Grade III glial tumors

被引:0
|
作者
Zorlu, F. [1 ]
Gurkaynak, M. [1 ]
Selek, U. [1 ]
Ulger, S. [1 ]
Turker, A. [2 ]
Kars, A. [2 ]
机构
[1] Hacettepe Univ, Oncol Hosp, Dept Radiat Oncol, Ankara, Turkey
[2] Hacettepe Univ, Oncol Hosp, Div Med Oncol, Ankara, Turkey
关键词
D O I
10.1016/j.ijrobp.2008.06.712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S235 / S235
页数:1
相关论文
共 50 条
  • [1] HYPOFRACTIONATED RADIOTHERAPY AND CONCOMITANT TEMOZOLOMIDE FOR HIGH-GRADE GLIAL TUMORS IN ELDERLY PATIENTS
    Kayali, Ilknur
    Habiboglu, Rahsan
    Saricanbaz, Iren
    Lehimcioglu, Yillar
    [J]. TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2019, 22 (01): : 32 - 37
  • [2] Temozolomide for childhood low-grade glial tumors
    Kuo, DJ
    Russo, S
    Brualdi, L
    Wisoff, J
    Miller, D
    Finlay, JL
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 248A - 248A
  • [3] Factors predicting recurrence in patients with grade III glial tumors: Impact of adjuvant temozolomide on recurrence
    Gumusay, Ozge
    Cetin, Bulent
    Ozet, Ahmet
    Demirci, Umut
    Buyukberber, Suleyman
    Coskun, Ugur
    Algin, Efnan
    Uner, Aytug
    Yildiz, Ramazan
    Kuri, Gokhan
    Benekli, Mustafa
    [J]. JOURNAL OF BUON, 2014, 19 (04): : 1035 - 1040
  • [4] Prognostic importance of markers for inflammation, angiogenesis and apoptosis in high grade glial tumors during temozolomide and radiotherapy
    Demirci, Umut
    Yaman, Melek
    Buyukberber, Suleyman
    Coskun, Ugur
    Baykara, Meltem
    Uslu, Kadriye
    Ozet, Ahmet
    Benekli, Mustafa
    Bagriacik, E. Umit
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2012, 14 (04) : 546 - 549
  • [5] Long term experience in high grade glial tumors with temozolomide
    Demirci, U.
    Buyukberber, S.
    Coskun, U.
    Akmansu, M.
    Yaman, E.
    Baykara, M.
    Yamac, D.
    Uner, A.
    Benekli, M.
    [J]. JOURNAL OF BUON, 2012, 17 (02): : 357 - 362
  • [6] The effects of radiotherapy on arterial diameters in patients with high-grade glial tumors who have undergone adjuvant radiotherapy
    Karaca, F.
    Mentes, S.
    Boga, Z.
    Akkaya, H.
    Keskin, S.
    Gulek, B.
    [J]. NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2023, 26 (03) : 300 - 306
  • [7] MENINGIOMA WHO GRADE II-III: TEMOZOLOMIDE WITH AND WITHOUT RADIATION IN THE MANAGEMENT OF WHO GRADE II AND III MENINGIOMAS
    Clark, Sarah
    Carlson, Julie A.
    Gaspar, Laurie E.
    Ney, Doug E.
    Chen, Changhu
    Kavanagh, Brian
    Damek, Denise M.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 59 - 59
  • [8] Concomitant radiotherapy and metronomic temozolomide in pediatric high-risk brain tumors
    Sterba, J
    Pavelka, Z
    Slampa, P
    [J]. NEOPLASMA, 2002, 49 (02) : 117 - 120
  • [9] RADIOTHERAPY WITH CONCOMITANT AND ADYUVANT TEMOZOLOMIDE WITH OR WITHOUT CARMUSTUNE WAFERS IN HIGH GRADE GLIOMA.
    Quiros, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S269 - S269
  • [10] Randomized phase III study of sequential radiochemotherapy of oligoastrocytic tumors of WHO-grade III with PCV or temozolomide: NOA-04
    Wolfgang, W. Wick
    Weller, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)